DE69814395D1 - Verfahren zur herstellung von alkoxyfuranon-amin-derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen - Google Patents

Verfahren zur herstellung von alkoxyfuranon-amin-derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen

Info

Publication number
DE69814395D1
DE69814395D1 DE69814395T DE69814395T DE69814395D1 DE 69814395 D1 DE69814395 D1 DE 69814395D1 DE 69814395 T DE69814395 T DE 69814395T DE 69814395 T DE69814395 T DE 69814395T DE 69814395 D1 DE69814395 D1 DE 69814395D1
Authority
DE
Germany
Prior art keywords
compounds
alkoxyfuranone
producing
amine derivatives
compounds obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69814395T
Other languages
English (en)
Other versions
DE69814395T2 (de
Inventor
Raphael Bouchet
Francis Brion
Colette Colladant
Jacques Lagouardat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69814395D1 publication Critical patent/DE69814395D1/de
Publication of DE69814395T2 publication Critical patent/DE69814395T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
DE69814395T 1997-07-15 1998-07-09 Verfahren zur herstellung von alkoxyfuranon-amin-derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen Expired - Lifetime DE69814395T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708932A FR2766188B1 (fr) 1997-07-15 1997-07-15 Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes
PCT/FR1998/001480 WO1999003852A1 (fr) 1997-07-15 1998-07-09 Procede de preparation de derives amines d'alkyloxyfuranone, composes issus de ce procede et utilisation de ces composes

Publications (2)

Publication Number Publication Date
DE69814395D1 true DE69814395D1 (de) 2003-06-12
DE69814395T2 DE69814395T2 (de) 2003-12-11

Family

ID=9509210

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69814395T Expired - Lifetime DE69814395T2 (de) 1997-07-15 1998-07-09 Verfahren zur herstellung von alkoxyfuranon-amin-derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen

Country Status (34)

Country Link
US (1) US6235899B1 (de)
EP (1) EP0998470B1 (de)
JP (1) JP4450987B2 (de)
KR (1) KR100519691B1 (de)
CN (1) CN100363355C (de)
AP (1) AP1071A (de)
AR (1) AR015924A1 (de)
AT (1) ATE239713T1 (de)
AU (1) AU744272B2 (de)
BG (1) BG64050B1 (de)
BR (1) BR9810896A (de)
CA (1) CA2296742C (de)
CZ (1) CZ295312B6 (de)
DE (1) DE69814395T2 (de)
DK (1) DK0998470T3 (de)
EA (1) EA002883B1 (de)
EE (1) EE03873B1 (de)
ES (1) ES2197489T3 (de)
FR (1) FR2766188B1 (de)
HR (1) HRP20000027B1 (de)
HU (1) HU230148B1 (de)
ID (1) ID23784A (de)
IL (1) IL134031A (de)
ME (1) ME01708B (de)
NO (1) NO324508B1 (de)
NZ (1) NZ502338A (de)
PL (1) PL200820B1 (de)
PT (1) PT998470E (de)
RS (1) RS49832B (de)
SK (1) SK284168B6 (de)
TR (1) TR200000117T2 (de)
UA (1) UA66364C2 (de)
WO (1) WO1999003852A1 (de)
ZA (1) ZA986203B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053056B2 (en) * 1998-07-02 2006-05-30 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
ATE472539T1 (de) * 2000-04-24 2010-07-15 Vertex Pharma Verfahren und zwischenprodukte zur herstellung von substituierten asparaginsäure-acetalen
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
JP2003327568A (ja) * 2000-09-20 2003-11-19 Kanegafuchi Chem Ind Co Ltd 光学活性β−アミノ酸誘導体の製造方法
JPWO2002055478A1 (ja) * 2001-01-16 2004-05-13 鐘淵化学工業株式会社 光学活性アミノラクトン誘導体の製造法およびその中間体
US7652153B2 (en) 2004-02-27 2010-01-26 Vertex Pharmaceuticals Incorporated Caspase inhibitors and uses thereof
SG150546A1 (en) * 2004-03-12 2009-03-30 Vertex Pharma Processes and intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
SK284168B6 (sk) 2004-10-05
PL200820B1 (pl) 2009-02-27
HRP20000027A2 (en) 2000-10-31
IL134031A0 (en) 2001-04-30
HU230148B1 (hu) 2015-09-28
HUP0003857A3 (en) 2002-08-28
BG64050B1 (bg) 2003-11-28
CN100363355C (zh) 2008-01-23
EE03873B1 (et) 2002-10-15
KR20010021834A (ko) 2001-03-15
US6235899B1 (en) 2001-05-22
EA002883B1 (ru) 2002-10-31
DK0998470T3 (da) 2003-09-01
BR9810896A (pt) 2000-09-26
AU8633398A (en) 1999-02-10
KR100519691B1 (ko) 2005-10-13
BG104073A (en) 2001-05-31
NO20000182D0 (no) 2000-01-14
CA2296742A1 (fr) 1999-01-28
NZ502338A (en) 2001-09-28
DE69814395T2 (de) 2003-12-11
YU1500A (sh) 2002-10-18
NO20000182L (no) 2000-03-07
AR015924A1 (es) 2001-05-30
UA66364C2 (uk) 2004-05-17
EA200000127A1 (ru) 2000-08-28
ES2197489T3 (es) 2004-01-01
AP2000001732A0 (en) 2000-03-31
TR200000117T2 (tr) 2000-07-21
SK302000A3 (en) 2000-11-07
HRP20000027B1 (en) 2006-07-31
FR2766188A1 (fr) 1999-01-22
EE200000024A (et) 2000-10-16
ATE239713T1 (de) 2003-05-15
CZ295312B6 (cs) 2005-07-13
CZ200065A3 (cs) 2000-07-12
IL134031A (en) 2004-06-01
AP1071A (en) 2002-05-20
ZA986203B (en) 1999-08-18
HUP0003857A2 (hu) 2001-04-28
ID23784A (id) 2000-05-11
RS49832B (sr) 2008-08-07
NO324508B1 (no) 2007-11-05
JP2001510191A (ja) 2001-07-31
CA2296742C (fr) 2009-12-08
CN1269795A (zh) 2000-10-11
ME01708B (me) 2008-08-07
JP4450987B2 (ja) 2010-04-14
AU744272B2 (en) 2002-02-21
EP0998470A1 (de) 2000-05-10
WO1999003852A1 (fr) 1999-01-28
FR2766188B1 (fr) 2000-02-11
PL338035A1 (en) 2000-09-25
PT998470E (pt) 2003-09-30
EP0998470B1 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
DE69320805D1 (de) Verfahren zur herstellung von cyclopentadien-metallkomplex verbindungen und verfahren zur verwendung
ATE360608T1 (de) Verfahren zur herstellung von 1,3-diolen
DE69413727D1 (de) Verfahren zur Herstellung von Kohlenstoffdioxid-Absorptionsmittel durch Verwendung von Betonschlamm
DE69830659D1 (de) Leitgährige zusammensetzung,verbundstoff dafür und verfahren zur herstellung dieser zusammensetzung und dieses verbundstoffes
DE69427540D1 (de) Verfahren zur herstellung von sufentanil derivaten durch carbene addition/aminolyse von 4-piperidon
DE69407624D1 (de) Verfahren zur herstellung von sialon-verbundwerkstoffen
DE69900546D1 (de) Verfahren zur herstellung von gamma-butyrolacton
DE69841108D1 (de) Verfahren zur herstellung von siliziumkarbideinkristallen
DE69504196D1 (de) Verfahren zur herstellung von siliciumcarbid
DE69533582D1 (de) Verfahren zur herstellung von wasserstoffcyanid
DE3676683D1 (de) Mischung von derivaten von aminosaeuren, verfahren zur herstellung der mischung und verwendung der mischung zur mengenbestimmung der aminosaeuren.
ATE267812T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
ATE190974T1 (de) Verfahren zur herstellung von n,n'- disubstituierten cyclischen harnstoffen
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
ATA294087A (de) Verfahren zur herstellung von 5,6-dihydroxyindol und dessen 3-alkylderivat, zwischenverbindungen und verwendung
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
DE69709655D1 (de) Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen
ATE239713T1 (de) Verfahren zur herstellung von alkoxyfuranon-amin- derivaten, durch dieses verfahren erhaltene verbindungen und verwendung dieser verbindungen
DE69522807D1 (de) Verfahren zur herstellung von feinkörnigen, modifizierten stärken
ATE238994T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
ATE226198T1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE214686T1 (de) Verfahren zur herstellung von fluorverbindungen aus den entsprechenden aminen
ATE366251T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
DE60044900D1 (de) Ein verbessertes verfahren zur herstellung von alkylpolyglycosiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC